# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017861
Filing Date
2023-11-07
Accepted
2023-11-07 07:40:39
Documents
96
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | xoma-20230930x10q.htm iXBRL | 10-Q | 2558027
2 | EX-31.1 | xoma-20230930xex31d1.htm | EX-31.1 | 10616
3 | EX-31.2 | xoma-20230930xex31d2.htm | EX-31.2 | 10618
4 | EX-32.1 | xoma-20230930xex32d1.htm | EX-32.1 | 8739
| Complete submission text file | 0001558370-23-017861.txt |  | 11177206

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | xoma-20230930.xsd | EX-101.SCH | 93871
6 | EX-101.CAL | xoma-20230930_cal.xml | EX-101.CAL | 47610
7 | EX-101.DEF | xoma-20230930_def.xml | EX-101.DEF | 491169
8 | EX-101.LAB | xoma-20230930_lab.xml | EX-101.LAB | 676038
9 | EX-101.PRE | xoma-20230930_pre.xml | EX-101.PRE | 664574
90 | EXTRACTED XBRL INSTANCE DOCUMENT | xoma-20230930x10q_htm.xml | XML | 1912651

Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 231381607
SIC: 2834 Pharmaceutical Preparations